Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Donald Bodenner

Concepts (286)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Thyroid Neoplasms
14
2017
112
1.990
 Why?
Thyroidectomy
13
2019
60
1.840
 Why?
Thyroid Diseases
8
2019
27
1.450
 Why?
Parathyroidectomy
8
2018
46
1.300
 Why?
Parathyroid Neoplasms
5
2015
28
1.090
 Why?
Thyroid Gland
8
2017
75
1.090
 Why?
Parathyroid Hormone
8
2019
149
0.960
 Why?
Vitamin D Deficiency
5
2019
44
0.950
 Why?
Adenoma
4
2017
113
0.950
 Why?
Vitamin D
4
2015
87
0.820
 Why?
Fluorodeoxyglucose F18
6
2013
189
0.740
 Why?
Positron-Emission Tomography
7
2013
293
0.730
 Why?
Radiopharmaceuticals
7
2015
204
0.720
 Why?
Carcinoma, Papillary
4
2017
47
0.710
 Why?
Ambulatory Surgical Procedures
4
2014
52
0.690
 Why?
Hyperparathyroidism, Primary
4
2018
36
0.660
 Why?
Iodine Radioisotopes
4
2015
35
0.610
 Why?
Hyperparathyroidism
2
2015
31
0.590
 Why?
Megestrol Acetate
2
2007
17
0.530
 Why?
Parathyroid Diseases
2
2016
5
0.530
 Why?
Bone Density Conservation Agents
2
2007
74
0.510
 Why?
Nursing Homes
2
2007
111
0.510
 Why?
Incidental Findings
3
2013
39
0.480
 Why?
Proton Pump Inhibitors
1
2015
83
0.470
 Why?
Diphosphonates
1
2015
90
0.470
 Why?
Academic Medical Centers
2
2012
149
0.460
 Why?
Thyroglobulin
2
2013
7
0.450
 Why?
Aged
20
2017
9743
0.440
 Why?
Parathyroid Glands
5
2018
21
0.430
 Why?
Carcinoma, Medullary
2
2010
12
0.430
 Why?
Middle Aged
26
2017
12614
0.430
 Why?
Male
32
2019
25910
0.390
 Why?
Hypothyroidism
2
2011
56
0.390
 Why?
Retrospective Studies
14
2019
6263
0.380
 Why?
Calcitonin
2
2010
30
0.370
 Why?
Postoperative Complications
5
2018
1033
0.370
 Why?
Humans
49
2019
50509
0.360
 Why?
Carcinoma
2
2012
137
0.350
 Why?
Algorithms
1
2013
628
0.340
 Why?
Thyroid Nodule
3
2017
31
0.330
 Why?
Female
31
2019
27086
0.320
 Why?
Weight Loss
2
2009
245
0.310
 Why?
Aged, 80 and over
10
2017
3228
0.290
 Why?
Appetite Stimulants
1
2007
5
0.280
 Why?
Cachexia
1
2007
25
0.280
 Why?
Receptors, Estrogen
2
2005
132
0.280
 Why?
Teriparatide
1
2007
10
0.270
 Why?
Four-Dimensional Computed Tomography
2
2017
28
0.260
 Why?
Hypocalcemia
2
2016
12
0.250
 Why?
Transcriptional Activation
2
2005
119
0.250
 Why?
Calcium
3
2018
398
0.250
 Why?
Pituitary Hormones, Anterior
1
2005
4
0.250
 Why?
Phenylurea Compounds
2
2015
15
0.250
 Why?
Hormones
1
2005
57
0.250
 Why?
Osteoporosis
1
2007
156
0.240
 Why?
Quinolines
2
2015
41
0.240
 Why?
Pituitary Gland
1
2005
85
0.240
 Why?
Receptors, Thyrotropin
2
2007
8
0.230
 Why?
Interleukin-6
1
2005
261
0.220
 Why?
NF-kappa B
1
2005
315
0.220
 Why?
Protein Kinase Inhibitors
2
2015
204
0.220
 Why?
Biopsy, Fine-Needle
5
2011
108
0.210
 Why?
Illinois
2
2013
10
0.210
 Why?
Treatment Outcome
8
2015
5285
0.200
 Why?
Adult
13
2017
13583
0.190
 Why?
Gene Expression Regulation
3
2005
955
0.190
 Why?
Aging
1
2005
694
0.170
 Why?
Young Adult
7
2015
4106
0.170
 Why?
Follow-Up Studies
3
2013
2241
0.160
 Why?
Hyperparathyroidism, Secondary
1
2019
4
0.160
 Why?
Postoperative Period
3
2015
171
0.160
 Why?
Thyroid Hormones
1
1998
20
0.160
 Why?
Receptors, Cytoplasmic and Nuclear
1
1998
68
0.150
 Why?
Receptors, Cell Surface
1
1998
116
0.150
 Why?
Preoperative Care
2
2018
169
0.150
 Why?
Vitamins
2
2018
63
0.150
 Why?
Patient Discharge
3
2016
321
0.140
 Why?
Intraoperative Complications
1
2019
114
0.140
 Why?
Insulin Resistance
2
2009
268
0.140
 Why?
United States
5
2015
4958
0.140
 Why?
Antineoplastic Agents
2
2015
1172
0.140
 Why?
Prospective Studies
2
2013
2378
0.140
 Why?
Predictive Value of Tests
3
2015
929
0.130
 Why?
Reoperation
1
2018
460
0.130
 Why?
Incidence
2
2011
1032
0.130
 Why?
Adolescent
5
2015
6447
0.120
 Why?
Hypoparathyroidism
1
2015
5
0.120
 Why?
Carcinoma, Neuroendocrine
1
2015
23
0.120
 Why?
Creatinine
1
2015
145
0.120
 Why?
Costs and Cost Analysis
2
2014
90
0.120
 Why?
Tomography, Emission-Computed, Single-Photon
1
2015
52
0.120
 Why?
Lymph Nodes
1
2017
257
0.120
 Why?
Disease Progression
3
2015
829
0.120
 Why?
Molecular Targeted Therapy
1
2015
123
0.120
 Why?
Diagnosis, Differential
6
2018
1033
0.110
 Why?
Ambulatory Care
1
2016
230
0.110
 Why?
Neoplasm Metastasis
2
2015
232
0.110
 Why?
Hospitals, University
1
2014
76
0.110
 Why?
Child, Preschool
2
2013
3944
0.110
 Why?
Sensitivity and Specificity
2
2013
861
0.110
 Why?
Exercise
2
2009
516
0.110
 Why?
Liver
2
2009
1132
0.110
 Why?
Drug Administration Schedule
1
2013
370
0.100
 Why?
Hospitals, Teaching
1
2013
54
0.100
 Why?
Technetium
1
2012
9
0.100
 Why?
Administration, Oral
1
2013
434
0.100
 Why?
Preoperative Period
1
2012
48
0.100
 Why?
Patient Compliance
1
2013
233
0.100
 Why?
Radionuclide Imaging
1
2012
116
0.100
 Why?
Outpatients
1
2013
117
0.100
 Why?
Clinical Competence
2
2018
398
0.100
 Why?
Hospital Charges
1
2012
44
0.100
 Why?
Tumor Burden
1
2012
130
0.100
 Why?
Struma Ovarii
1
2012
5
0.100
 Why?
Cost Savings
1
2012
57
0.100
 Why?
Prognosis
3
2015
1978
0.100
 Why?
Child
3
2013
6910
0.100
 Why?
Promoter Regions, Genetic
4
2007
465
0.100
 Why?
Ovariectomy
1
2012
115
0.090
 Why?
Immunohistochemistry
2
2012
957
0.090
 Why?
Obesity
2
2009
1121
0.090
 Why?
Chromogranin A
1
2010
5
0.090
 Why?
Dose-Response Relationship, Drug
1
2013
1372
0.090
 Why?
Radiation Monitoring
1
2010
7
0.090
 Why?
Checklist
1
2010
29
0.080
 Why?
Inpatients
1
2011
193
0.080
 Why?
Radiosurgery
1
2011
123
0.080
 Why?
Fatal Outcome
1
2010
197
0.080
 Why?
Databases, Factual
1
2013
674
0.080
 Why?
HeLa Cells
4
2005
247
0.080
 Why?
Multiple Endocrine Neoplasia Type 2a
1
2009
5
0.080
 Why?
Caloric Restriction
1
2009
35
0.080
 Why?
Ultrasonography
4
2015
435
0.080
 Why?
Proto-Oncogene Proteins c-ret
1
2009
33
0.080
 Why?
Intra-Abdominal Fat
1
2009
21
0.080
 Why?
General Surgery
1
2010
108
0.080
 Why?
Occupational Exposure
1
2010
113
0.080
 Why?
Blastomycosis
1
2008
34
0.070
 Why?
Symporters
1
2007
17
0.070
 Why?
Adenoma, Oxyphilic
1
2007
11
0.070
 Why?
Ovarian Neoplasms
1
2012
450
0.070
 Why?
Time Factors
3
2015
2934
0.070
 Why?
Severity of Illness Index
1
2011
978
0.070
 Why?
Anorexia
1
2007
7
0.070
 Why?
Whole Body Imaging
1
2007
26
0.070
 Why?
Adiposity
1
2009
137
0.070
 Why?
DNA, Neoplasm
1
2007
143
0.070
 Why?
Base Sequence
3
2005
639
0.070
 Why?
Calcifediol
1
2006
8
0.070
 Why?
Practice Management, Medical
1
2006
10
0.070
 Why?
Calcium Carbonate
1
2006
11
0.070
 Why?
Medical Audit
1
2006
21
0.070
 Why?
Drug Utilization Review
1
2006
23
0.070
 Why?
Drug Monitoring
1
2006
79
0.070
 Why?
Head
1
2006
71
0.070
 Why?
Cross-Sectional Studies
2
2014
1609
0.070
 Why?
Geriatrics
1
2006
45
0.060
 Why?
Thyrotropin
3
2002
49
0.060
 Why?
Gene Expression Regulation, Neoplastic
1
2010
833
0.060
 Why?
Otolaryngology
1
2006
61
0.060
 Why?
Body Mass Index
2
2009
677
0.060
 Why?
Neck
1
2006
99
0.060
 Why?
Proportional Hazards Models
1
2007
415
0.060
 Why?
Progesterone Congeners
1
2005
5
0.060
 Why?
Body Fat Distribution
1
2005
9
0.060
 Why?
Freezing
1
2005
16
0.060
 Why?
Faculty, Medical
1
2006
92
0.060
 Why?
Arkansas
2
2014
1984
0.060
 Why?
Serum
1
2005
32
0.060
 Why?
Fractures, Bone
1
2006
109
0.060
 Why?
Survival Analysis
1
2007
661
0.060
 Why?
DNA Primers
1
2005
206
0.060
 Why?
Reproducibility of Results
3
2017
1199
0.060
 Why?
Internship and Residency
1
2010
447
0.060
 Why?
Nuclear Proteins
1
2005
238
0.050
 Why?
Infant
1
2012
3630
0.050
 Why?
Protein Binding
1
2005
654
0.050
 Why?
Proto-Oncogene Proteins c-jun
2
1993
77
0.050
 Why?
ROC Curve
2
2015
226
0.050
 Why?
Patient Selection
2
2018
259
0.050
 Why?
Intraoperative Period
2
2015
45
0.050
 Why?
Randomized Controlled Trials as Topic
1
2005
573
0.050
 Why?
Mutation
2
2017
1281
0.050
 Why?
Tongue Diseases
1
2001
7
0.050
 Why?
Choristoma
1
2001
24
0.050
 Why?
Receptors, Androgen
1
2001
45
0.040
 Why?
Tomography, X-Ray Computed
3
2012
1169
0.040
 Why?
DNA-Binding Proteins
2
1993
418
0.040
 Why?
Thalidomide
1
2002
378
0.040
 Why?
Transcription Factors
2
1993
565
0.040
 Why?
Cohort Studies
2
2015
1452
0.040
 Why?
Glucagon
2
2009
23
0.040
 Why?
Monitoring, Intraoperative
1
2019
54
0.040
 Why?
Cholecalciferol
1
2018
22
0.040
 Why?
GTP-Binding Proteins
1
1998
91
0.040
 Why?
Hospitals, High-Volume
1
2018
25
0.040
 Why?
Medical History Taking
1
2018
48
0.040
 Why?
Autoantibodies
1
1998
115
0.040
 Why?
Risk Factors
1
2006
3724
0.040
 Why?
Pilot Projects
2
2010
699
0.040
 Why?
Methylene Blue
1
2017
9
0.040
 Why?
Lymphatic System
1
2017
13
0.040
 Why?
Societies, Medical
1
2018
187
0.030
 Why?
Animals, Genetically Modified
1
2017
48
0.030
 Why?
Coloring Agents
1
2017
66
0.030
 Why?
Mice, Inbred Strains
1
2017
160
0.030
 Why?
Insulin
2
2009
467
0.030
 Why?
Proto-Oncogene Proteins B-raf
1
2017
80
0.030
 Why?
Recurrence
1
2018
659
0.030
 Why?
Lymphatic Metastasis
1
2017
222
0.030
 Why?
Bone Density
1
2018
387
0.030
 Why?
Technetium Tc 99m Sestamibi
1
2015
18
0.030
 Why?
Retreatment
1
2015
56
0.030
 Why?
Brachial Plexus
1
2015
11
0.030
 Why?
Endocrinology
1
2015
11
0.030
 Why?
Axilla
1
2015
91
0.030
 Why?
Hematoma
1
2015
64
0.030
 Why?
Signal Transduction
1
2001
1624
0.030
 Why?
Transplantation, Autologous
1
2015
481
0.030
 Why?
Neoplasm Staging
1
2015
746
0.030
 Why?
Hernia, Abdominal
1
2012
4
0.020
 Why?
Activating Transcription Factor 1
1
2012
22
0.020
 Why?
Delayed Diagnosis
1
2012
24
0.020
 Why?
Mice
2
2017
5687
0.020
 Why?
Ribs
1
2010
15
0.020
 Why?
Thoracotomy
1
2010
35
0.020
 Why?
Mediastinal Neoplasms
1
2010
16
0.020
 Why?
Neck Dissection
1
2010
30
0.020
 Why?
Hypercalcemia
1
2010
33
0.020
 Why?
Feasibility Studies
1
2011
391
0.020
 Why?
Gas Chromatography-Mass Spectrometry
1
2009
68
0.020
 Why?
Hospitalization
1
2014
675
0.020
 Why?
Octreotide
1
2009
9
0.020
 Why?
Prevalence
1
2012
971
0.020
 Why?
Glucose Tolerance Test
1
2009
58
0.020
 Why?
Adiponectin
1
2009
46
0.020
 Why?
Enzyme-Linked Immunosorbent Assay
1
2009
234
0.020
 Why?
Absorptiometry, Photon
1
2009
156
0.020
 Why?
Postmenopause
1
2009
96
0.020
 Why?
Eye
1
2008
24
0.020
 Why?
Bone Neoplasms
1
2010
179
0.020
 Why?
Iodine
1
2007
9
0.020
 Why?
Methylation
1
2007
118
0.020
 Why?
Body Weight
1
2009
517
0.020
 Why?
Neoplasm Recurrence, Local
1
2011
629
0.020
 Why?
Multiple Myeloma
1
2002
2997
0.020
 Why?
Overweight
1
2009
215
0.020
 Why?
Current Procedural Terminology
1
2006
7
0.020
 Why?
Insurance, Health, Reimbursement
1
2006
24
0.020
 Why?
Office Visits
1
2006
44
0.020
 Why?
Polymerase Chain Reaction
1
2007
449
0.020
 Why?
Genetic Predisposition to Disease
1
2009
511
0.020
 Why?
Blood Glucose
1
2009
447
0.020
 Why?
Animals
2
2017
13124
0.020
 Why?
Risk Assessment
1
2010
1270
0.020
 Why?
Lung
1
2008
504
0.010
 Why?
Thyrotropin-Releasing Hormone
2
1993
5
0.010
 Why?
Tetradecanoylphorbol Acetate
2
1993
47
0.010
 Why?
Transcription Factor Pit-1
2
1993
20
0.010
 Why?
Muscle, Skeletal
1
2009
783
0.010
 Why?
Thyroid Function Tests
1
2002
25
0.010
 Why?
Molecular Sequence Data
2
1993
778
0.010
 Why?
src Homology Domains
1
2001
9
0.010
 Why?
Airway Obstruction
1
2001
47
0.010
 Why?
Androgens
1
2001
70
0.010
 Why?
Cytoplasm
1
2001
89
0.010
 Why?
Estrogen Receptor beta
1
2001
55
0.010
 Why?
src-Family Kinases
1
2001
51
0.010
 Why?
Estrogen Receptor alpha
1
2001
88
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
155
0.010
 Why?
Deglutition Disorders
1
2001
77
0.010
 Why?
Cell Nucleus
1
2001
182
0.010
 Why?
Binding Sites
1
2001
362
0.010
 Why?
Peptide Fragments
1
2001
209
0.010
 Why?
Clinical Trials as Topic
1
2002
486
0.010
 Why?
Estrogens
1
2001
226
0.010
 Why?
Fibroblasts
1
2001
336
0.010
 Why?
Sex Factors
1
2001
712
0.010
 Why?
Osteoblasts
1
2001
462
0.010
 Why?
Osteoclasts
1
2001
427
0.010
 Why?
Apoptosis
1
2001
1097
0.010
 Why?
Oligodeoxyribonucleotides
1
1993
33
0.010
 Why?
Mutagenesis, Site-Directed
1
1993
95
0.010
 Why?
RNA, Messenger
1
1993
1089
0.010
 Why?
Cell Line
1
1993
988
0.010
 Why?
DNA
1
1993
535
0.010
 Why?
Bodenner's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (286) concept(s)
_
Co-Authors Expand Description
See all (17) people
_
Similar People Expand Description
See all (32) people
_
Same Department Expand Description
Search Department